ScholarIQanswers from OpenAlex & ORCID
David G. Maloney
ResearcherPublications, citations & collaboration network
David G. Maloney is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does David G. Maloney have?
ScholarIQindexed works
David G. Maloney has 840 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does David G. Maloney have?
ScholarIQcitation count
David G. Maloney has 54,270 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of David G. Maloney?
ScholarIQh-index
David G. Maloney has an h-index of 111 in OpenAlex.
What is the i10-index of David G. Maloney?
ScholarIQi10-index
David G. Maloney has an i10-index of 363 in OpenAlex.
What is the ORCID of David G. Maloney?
ScholarIQorcid
The ORCID for David G. Maloney is on the source record.
What is the OpenAlex record for David G. Maloney?
ScholarIQopenalex
The OpenAlex for David G. Maloney is on the source record.
What are the most-cited papers on David G. Maloney?
ScholarIQmost cited works
Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects
Peter A. McSweeney, Dietger Niederwieser, Judith A. Shizuru, Brenda M. Sandmaier, Arthur J. Molina, David G. Maloney, Thomas R. Chauncey, Theodore A. Gooley, Ute Hegenbart, Richard A. Nash, Jerald P. Radich, John L. Wagner, Steven T. Minor, Frederick R. Appelbaum, William Bensinger, Eileen Bryant, Mary E.D. Flowers, George E. Georges, F. Carl Grumet, Hans‐Peter Kiem, Beverly Torok‐Storb, Cong Yu, Karl G. Blume, Rainer Storb
Factors associated with durable EFS in adult B-cell ALL patients achieving MRD-negative CR after CD19 CAR T-cell therapy
Kevin A. Hay, Jordan Gauthier, Alexandre V. Hirayama, Jenna Voutsinas, Qian Wu, Daniel Li, Ted Gooley, Sindhu Cherian, Xueyan Chen, Barbara S. Pender, Reed M. Hawkins, Aesha Vakil, Rachel N. Steinmetz, Gary Schoch, Aude G. Chapuis, Brian G. Till, Hans‐Peter Kiem, Jorge Ramos, Mazyar Shadman, Ryan D. Cassaday, Utkarsh Acharya, Stanley R. Riddell, David G. Maloney, Cameron J. Turtle
Late Events after Treatment with CD19-Targeted Chimeric Antigen Receptor Modified T Cells
Ana Cordeiro, Evandro D. Bezerra, Alexandre V. Hirayama, Joshua A. Hill, Qian Wu, Jenna Voutsinas, Mohamed L. Sorror, Cameron J. Turtle, David G. Maloney, Merav Bar
The response to lymphodepletion impacts PFS in patients with aggressive non-Hodgkin lymphoma treated with CD19 CAR T cells
Alexandre V. Hirayama, Jordan Gauthier, Kevin A. Hay, Jenna Voutsinas, Qian Wu, Ted Gooley, Daniel Li, Sindhu Cherian, Xueyan Chen, Barbara S. Pender, Reed M. Hawkins, Aesha Vakil, Rachel N. Steinmetz, Utkarsh Acharya, Ryan D. Cassaday, Aude G. Chapuis, Tejaswini Dhawale, Paul C. Hendrie, Hans‐Peter Kiem, Ryan C. Lynch, Jorge Ramos, Mazyar Shadman, Brian G. Till, Stanley R. Riddell, David G. Maloney, Cameron J. Turtle
Long-term Outcomes Among Older Patients Following Nonmyeloablative Conditioning and Allogeneic Hematopoietic Cell Transplantation for Advanced Hematologic Malignancies
Mohamed L. Sorror, Brenda M. Sandmaier, Barry E. Storer, Georg‐Nikolaus Franke, Ginna G. Laport, Thomas R. Chauncey, Edward Agura, Richard T. Maziarz, Amelia Langston, Parameswaran Hari, Michael A. Pulsipher, Wolfgang Bethge, Firoozeh Sahebi, Benedetto Bruno, Michael B. Maris, Andrew M. Yeager, Finn Bo Petersen, Lars L. Vindeløv, Peter A. McSweeney, Kai Hübel, Marco Mielcarek, George E. Georges, Dietger Niederwieser, Karl G. Blume, David G. Maloney, Rainer Storb